Exposure of Mycobacteria to Cell Wall-inhibitory Drugs Decreases Production of Arabinoglycerolipid Related to Mycolyl-arabinogalactan-peptidoglycan Metabolism

[摘要]：Background: Mycolyl-arabinogalactan-peptidoglycan (mAGP) represents the hallmark of the mycobacterial cell envelope and the target of several antitubercular drugs. Results: Loss of a glycolipid structurally analogous to the terminal portion of mAGP correlates with drug treatment in mycobacteria. Conclusion: This work establishes the versatility of arabinoglycerolipids in M. tuberculosis. Significance: Further work will define the importance of the metabolic relationship between the two components in cell wall remodeling and/or pathogenesis.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内